台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    63.4
  • 漲跌
    ▲0.1
  • 漲幅
    +0.16%
  • 成交量
    237
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元富-安南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-安南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/21062.2000.0063.300940.02%
2024/11/20168.5200.0064.401911.13%
2024/11/19069.1000.0069.300880.02%
2024/11/14171.0500.0069.7011020.99%
2024/11/131177.48377.4077.408978.18%
2024/11/12186.0100.0086.001901.12%
2024/10/28196.4000.0096.4011350.74%
2024/10/04197.0000.0097.0011380.72%
2024/09/11296.4000.0096.1021391.44%
2024/09/1000.000.198.5096.50-0.1139-0.05%
2024/08/2100.001102.50102.00-1135-0.74%
2024/08/191107.5000.00106.0011300.77%
2024/08/1310103.5000.00101.50101099.16%
2024/08/0900.000.498.40100.50-0.493-0.46%
2024/08/05099.0000.0098.800890.01%
2024/07/2600.004.1100.51101.00-4.189-4.53%
2024/07/2300.000101.00101.500900.00%
2024/07/180102.0000.00101.500900.00%
2024/07/1200.000.5101.50102.00-0.593-0.54%
2024/07/1100.000.1102.00101.50-0.194-0.13%
2024/06/180101.0000.00101.0001450.00%
2024/06/071102.5000.00102.5011550.64%
2024/05/1700.000.5105.50105.50-0.5152-0.33%
2024/05/140.6102.6900.00102.000.61440.41%
2024/05/130.2107.000107.00107.000.21270.13%
2024/04/240117.5000.00118.0001150.03%
2024/04/1700.000116.50117.0001110.00%
2024/04/110.1119.000119.50119.500.11010.10%
2024/04/100.1126.5000.00127.000.1950.05%
2024/04/080124.0000.00123.500730.00%
2024/03/2900.000.1123.50122.00-0.168-0.07%
2024/03/261123.0000.00123.001631.57%
2024/03/250.1123.501123.50124.00-0.962-1.44%
2024/03/220.1124.0000.00122.500.1600.08%
2024/03/190.2121.5000.00123.000.2550.36%
2024/03/151121.0000.00121.501472.12%
2023/12/2500.000.2114.38114.50-0.224-0.96%
2023/10/120117.0000.00117.000250.02%
2023/10/030115.0000.00116.000260.02%
2023/09/220114.0000.00114.000260.05%
2023/09/190114.0000.00114.000260.02%
2023/09/150114.5000.00114.000260.02%
2023/09/070112.5000.00112.500270.02%
2023/08/310112.5000.00111.500300.02%
2023/08/170112.5000.00110.500310.02%
2023/08/040111.0000.00111.500300.02%
2023/07/210109.5000.00109.000290.02%
2023/07/060108.0000.00107.500420.01%
2023/06/290109.0000.00108.500460.01%
2023/06/150109.0000.00109.000550.01%
2023/06/050109.0000.00108.000550.01%
2023/05/2200.002109.00109.00-256-3.55%
2023/05/150108.5000.00107.500550.01%
2023/04/121119.0000.00119.001422.35%
2023/02/1300.000109.00107.50037-0.03%
2023/01/3000.001108.00108.50-139-2.52%
2022/12/261107.0000.00107.001402.50%
2022/12/230103.0000.00103.000380.04%
2022/12/130104.0000.00104.000380.02%
2022/12/061102.0000.00102.001342.94%
2022/11/211100.0000.00100.501234.28%
2022/11/0700.001102.00102.50-119-5.24%
2022/10/250100.0000.00100.000150.06%
2022/10/240100.0000.00100.000150.04%
2022/10/190101.5000.00101.000150.04%
2022/10/171102.0000.00102.001146.77%
2022/09/050109.0000.00108.000170.11%
2022/08/110112.0000.00113.000240.07%
2022/08/100111.0000.00112.000260.07%
2022/07/130103.0000.00103.000420.05%
2022/07/110100.0000.00100.500420.05%
2022/06/27098.4000.0098.800460.01%
2022/06/1300.001100.00100.00-146-2.16%
2022/04/180126.5000.00125.000250.05%
2022/04/060133.5000.00134.500220.06%
2022/03/010.2125.0000.00126.000.2220.92%
2022/02/240.2125.0000.00124.500.2210.92%
2021/11/090.2125.5000.00124.500.2290.67%
2021/09/240142.0000.00141.500340.07%
2021/09/100.1142.5000.00143.500.1340.29%
2021/03/190.1134.5000.00136.000.1250.39%
2020/12/3100.002122.50123.00-232-6.10%
2020/11/1700.001119.00118.50-133-2.97%
2020/09/3000.002113.50113.00-235-5.62%
2020/08/121107.5000.00108.001571.74%
2020/08/1100.001107.50108.00-157-1.73%
2020/07/081106.5000.00107.001621.60%
2020/06/242115.0000.00116.002593.34%
2020/06/122109.5000.00110.002533.71%
2020/06/0900.002113.50113.50-255-3.60%
2020/05/152109.2500.00108.002503.97%
2020/03/30194.0000.0094.501412.39%
2019/10/300.2101.0000.00101.500.2210.92%
2019/09/110.2102.0000.00102.000.2410.43%
2019/09/090101.5000.00101.500410.06%
2019/05/3000.000.8109.50110.50-0.841-1.92%
2018/10/091101.5000.00101.501432.30%
2018/10/0200.001106.00106.00-146-2.16%
2018/09/070.1106.0000.00106.000.1520.09%
2018/09/050.2108.0000.00108.500.2520.38%
2018/06/190.2124.5000.00124.000.21020.22%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音